GAO Report on Medicare Fraud Risks and Data Analytics
The Government Accountability Office (GAO) has released a report highlighting significant fraud risks in Medicare, underscoring the vital role of data analytics in mitigating these challenges. The Centers for Medicare & Medicaid Services (CMS) have reportedly intercepted billions in potentially fraudulent expenditures by pinpointing unusual billing activities and enforcing administrative measures against providers.
Medicare is consistently viewed as a high-risk program by the GAO due to its complexity and vulnerability to fraud. Scams frequently target specific service categories, such as durable medical equipment, and involve manipulating Medicare beneficiary information to submit claims for unnecessary or non-existent services.
CMS extensively utilizes data analytics to scrutinize claims and identify irregularities. This technology detects abnormal billing patterns, indicating possible fraud, enabling CMS to initiate investigations and administer corrective actions, such as payment suspensions. A notable case involved 15 healthcare providers who allegedly billed over $4 billion for undelivered urinary catheters. Through analytics, CMS detected the scheme, halted payments, and terminated the providers' enrollments.
Based on GAO's assessment of CMS's efforts from fiscal years 2022 to 2024, administrative actions prevented approximately $11.9 billion in potentially fraudulent payments. Key interventions included revoking and deactivating provider accounts and suspending payments.
A challenge identified is the limited information exchange with supplemental payers. Until December 2025, CMS had not been sharing payment suspension data with private insurers and state Medicaid programs. This communication gap led these entities to occasionally cover cost-sharing obligations tied to fraudulent claims. Private insurers reported losses in the tens of millions due to schemes like the urinary catheter fraud, while state Medicaid agencies paid at least $196,000 for similar claims during 2023 and 2024. CMS has now initiated data sharing to reduce redundant payments across the healthcare sector.
The GAO's review aimed to evaluate CMS’s application of data analytics, assess common fraud schemes, and determine the effectiveness of information exchange with stakeholders. The report analyzed CMS data from fiscal years 2022 through 2024 and included discussions with officials, contractors, and private payers involved in fraud prevention. The findings underscore the necessity for continued investment in data analytics and enhanced collaboration among payers to safeguard Medicare resources.